Aridis Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.17
|
-0.47
|
-0.30
|
-176.47%
|
|
2022-06-30
|
-0.06
|
-0.45
|
-0.39
|
-650.00%
|
|
2022-03-31
|
-0.41
|
-0.92
|
-0.51
|
-124.39%
|
|
2021-12-31
|
-0.45
|
-0.92
|
-0.47
|
-102.96%
|
|
2021-09-30
|
-0.51
|
-1.94
|
-1.43
|
-280.39%
|
|
2021-06-30
|
-0.63
|
-0.49
|
0.14
|
22.22%
|
|
2021-03-31
|
-0.62
|
-0.77
|
-0.15
|
-24.19%
|
|
2020-12-31
|
-0.59
|
-0.59
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.84
|
|
2021-12-31
|
-4.12
|
|
2020-12-31
|
-2.34
|
|
2019-12-31
|
-3.52
|
|
2018-12-31
|
-15.14
|
|
2017-12-31
|
-2.75
|